CHEPLAPHARM Arzneimittel GmbH
support_agent

Your contact persons

DORMICUM®

Active ingredient:

Midazolam

Therapeutic area:

Neuropsychiatry

DORMICUM®, with its active ingredient midazolam, belongs to the pharmaceutical group of benzodiazepines representing a centrally depressant psychotropic drug that exerts anxiolytic, anticonvulsant, and muscle-relaxant effects. Midozolam is included in the WHO list of essential medicines in the section preoperative medication and sedation for short-term procedures.

DORMICUM® is available as film-coated tablet as well as solution for injection containing midazolam in various strengths. It is indicated for short-term treatment of severe or disabling insomnia, sedation in premedication of anaesthesia and for diagnostic or surgical procedures as well as for sedation in intensive care units.

Back to top expand_less